Currently a postdoctoral researcher focused on developing a novel TBE vaccine using the Langat virus platform. Concurrently, I am involved in the collaborative HEKLA-SE TBE project, which aims to enhance TBE surveillance in Nordic countries. Additionally, I am part of a project dedicated to developing a vaccine against viral hepatitis.

Member of the DevelopVaccines@ORU team, working on Work Package 4: Developing a novel TBE vaccine with a focus on mucosal immunization.

PhD degree obtained with a thesis project centered on studying measles outbreaks in France. Utilized genomic and serological investigation techniques to analyze recent outbreaks, particularly in Southern France, specifically Marseille. Gained expertise in virology, clinical aspects of the disease, epidemiology, and assessing vaccine efficacy.In parallel, conducted non-thesis related studies in the virology field during the COVID-19 pandemic, focusing on assessing the immunogenicity and infectivity of SARS-CoV-2 and its variants in human

Obtained an MSc degree in Infectious Disease and Microbiota from Aix-Marseille University. Completed a 6-month Master internship focusing on giant viruses of amoeba and their virophages. Project involved phenotypic and genetic characterization of a new virophage associated with giant viruses.